Literature DB >> 15879614

The enigma of primary biliary cirrhosis.

Carlo Selmi1, Yasunori Ichiki, Pietro Invernizzi, Mauro Podda, M Eric Gershwin.   

Abstract

Primary biliary cirrhosis (PBC) is a chronic cholestatic disease characterized by a striking predominance in female patients (with most cases diagnosed between ages 40 and 60 yr) as well as serum auto-antibodies to mitochondrial antigens, elevated serum immunoglobulin M,progressive destruction of intrahepatic bile ducts, and, ultimately, liver cirrhosis and failure(1). The precise mechanisms leading to selective destruction of biliary epithelial cells lining intrahepatic bile ducts are still unknown, although numerous immunomediated pathways have been proposed. Genetic background appears to be important in determining susceptibility to the disease (2), but no clear association with alleles in the major histocompatibility complex has been identified. Molecular mimicry either by infections (3) or xenobiotics (4) has been proposed to be capable of breaking tolerance in genetically predisposed individuals, thus leading to onset of PBC. This article describes and discusses the available data regarding the immunomediated pathogenesis of PBC (with particular attention to auto-antibodies and autoreactive T-cells) and presents the recent evidence indicating a role for either xenobiotic chemicals or novel infectious agents in the induction of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879614     DOI: 10.1385/CRIAI:28:2:073

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  72 in total

Review 1.  Molecular mimicry and primary biliary cirrhosis: premises not promises.

Authors:  J Van de Water; H Ishibashi; R L Coppel; M E Gershwin
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

2.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

Review 4.  Primary biliary cirrhosis.

Authors:  M M Kaplan
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

5.  Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression.

Authors:  M D Van Norstrand; M Malinchoc; K D Lindor; T M Therneau; M E Gershwin; P S Leung; E R Dickson; H A Homburger
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

6.  Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.

Authors:  M A Atkinson; M A Bowman; L Campbell; B L Darrow; D L Kaufman; N K Maclaren
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment.

Authors:  J Quinn; A G Diamond; J M Palmer; M F Bassendine; O F James; S J Yeaman
Journal:  Hepatology       Date:  1993-12       Impact factor: 17.425

8.  Subpopulations of primed T helper cells in rheumatoid arthritis.

Authors:  N Matthews; P Emery; D Pilling; A Akbar; M Salmon
Journal:  Arthritis Rheum       Date:  1993-05

Review 9.  Bacteria and human autoimmunity: the case of primary biliary cirrhosis.

Authors:  Carlo Selmi; M Eric Gershwin
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

Review 10.  Epidemiology and pathogenesis of primary biliary cirrhosis.

Authors:  Carlo Selmi; Pietro Invernizzi; Emmet B Keeffe; Ross L Coppel; Mauro Podda; Lorenzo Rossaro; Aftab A Ansari; M Eric Gershwin; Emmet B Keefe
Journal:  J Clin Gastroenterol       Date:  2004-03       Impact factor: 3.062

View more
  5 in total

Review 1.  Autoimmunity and environment: am I at risk?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Harold Baum; Andrew K Burroughs; Diego Vergani; Dimitrios P Bogdanos
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 2.  Primary biliary cirrhosis.

Authors:  Douglas L Nguyen; Brian D Juran; Konstantinos N Lazaridis
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-10       Impact factor: 3.043

3.  Hepatic IL-17 responses in human and murine primary biliary cirrhosis.

Authors:  Ruth Y Z Lan; Thucydides L Salunga; Koichi Tsuneyama; Zhe-Xiong Lian; Guo-Xiang Yang; Willy Hsu; Yuki Moritoki; Aftab A Ansari; Claudia Kemper; Jeff Price; John P Atkinson; Ross L Coppel; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-12-19       Impact factor: 7.094

4.  Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis.

Authors:  Dong-Yu Liang; Yan-Qiang Hou; Li-Jun Luo; Li Ao
Journal:  Int J Mol Med       Date:  2016-05-27       Impact factor: 4.101

5.  Detection of Anti-mitochondrial Antibodies Accompanied by Drug-induced Hepatic Injury due to Atorvastatin.

Authors:  Noriyuki Kuniyoshi; Hiroshi Miyakawa; Kotaro Matsumoto; Hiromichi Tsunashima; Katsunori Sekine; Takayuki Tsujikawa; Masatoshi Mabuchi; Shinpei Doi; Kentaro Kikuchi
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.